Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-Country Prospective Real-World Study to Validate the CLCI Instrument (DermCLCI-p) in Patients With Moderate-to-Severe Chronic Plaque Psoriasis (IMMagine)

NCT05959070 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT05959070
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05959070 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-Country Prospective Real-World Study to Validate the CLCI Instrument (DermCLCI-p) in Patients With Moderate-to-Severe Chronic Plaque Psoriasis (IMMagine)
Lead sponsor
AbbVie
Phase
Observational
Overall status
Completed
Start date
November 9, 2023
Completion date
March 21, 2025
Enrollment
154 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis